These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9736309)

  • 1. Lipid oxidation products and vascular function.
    Bruckdorfer KR
    Free Radic Res; 1998 Jun; 28(6):573-81. PubMed ID: 9736309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of oxidized lipoproteins, oxidation products and antioxidants on the release of nitric oxide from the endothelium and the response of platelets to nitric oxide.
    Bruckdorfer KR; Naseem KM; Mohammadi B; Chirico S; Ettelaie C; Gleeson A; Young T; Adam JM; Wilbourn B; Skinner VO; Goodall AH; Khan J; Gates SC; Jacobs M
    Biofactors; 1997; 6(2):191-9. PubMed ID: 9260001
    [No Abstract]   [Full Text] [Related]  

  • 3. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation.
    Bloodsworth A; O'Donnell VB; Freeman BA
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1707-15. PubMed ID: 10894807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chylomicron-remnant-like particles inhibit the basal nitric oxide pathway in porcine coronary artery and aortic endothelial cells.
    Goulter AB; Avella M; Botham KM; Elliott J
    Clin Sci (Lond); 2003 Sep; 105(3):363-71. PubMed ID: 12757429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of plasma lipoproteins on platelet responsiveness and on platelet and vascular prostanoid synthesis.
    Bruckdorfer KR
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(4):247-54. PubMed ID: 2561310
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
    Tanner FC; Noll G; Boulanger CM; Lüscher TF
    Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized lipoproteins induce long-lasting inhibition of nitric oxide synthase from a murine endothelioma cell line (bEnd.4).
    Fogliatto G; Musanti R; Pirillo A; Ghiselli G
    J Cardiovasc Risk; 1995 Apr; 2(2):123-30. PubMed ID: 7541706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of reactive oxygen species in endothelial cells by peroxynitrite-treated lipoproteins.
    Matsunaga T; Nakajima T; Sonoda M; Koyama I; Kawai S; Inoue I; Katayama S; Hirano K; Hokari S; Komoda T
    J Biochem; 2001 Aug; 130(2):285-93. PubMed ID: 11481047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
    Warner TD
    Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory role of lipoprotein oxidation on platelet-vessel wall interactions.
    Bruckdorfer KR
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):493-7. PubMed ID: 9430402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle and endothelial functions in aging.
    Yildiz O
    Ann N Y Acad Sci; 2007 Apr; 1100():353-60. PubMed ID: 17460198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids and the endothelium.
    Dart AM; Chin-Dusting JP
    Cardiovasc Res; 1999 Aug; 43(2):308-22. PubMed ID: 10536661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent regulation of the cardiovascular system.
    Shimokawa H; Takeshita A
    Intern Med; 1995 Oct; 34(10):939-46. PubMed ID: 8563093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous nitric oxide and the vascular endothelium.
    Dusting GJ
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():271-6. PubMed ID: 2526483
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelium-derived relaxing factor (nitric oxide), lipoprotein oxidation and atherosclerosis.
    Bruckdorfer KR; Jacobs M; Rice-Evans C
    Biochem Soc Trans; 1990 Dec; 18(6):1061-3. PubMed ID: 2088806
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system.
    Lüscher TF
    Eur Heart J; 1991 Nov; 12 Suppl E():2-11. PubMed ID: 1790780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
    Ignarro LJ
    Circ Res; 1989 Jul; 65(1):1-21. PubMed ID: 2544316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.